XML 65 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Investments In Subsidiaries
12 Months Ended
Dec. 31, 2022
Disclosure of subsidiaries [abstract]  
Note 8 - Investments in Subsidiaries
Note 8 - Investments in Subsidiaries
 
  A.
Non-controlling interests in subsidiaries
 
The following tables present information with respect to non-controlling interests in a subsidiary, YPH (at the rate of 50%), before elimination of inter-company transactions. The information includes fair value adjustments that were made on the acquisition date, other than goodwill and presented without adjustments for the ownership rates held by the Company.
 
 
As of December 31
 
2022
2021
 
$ millions
$ millions
 
Current assets
267
231
Non-current assets
392
408
Current liabilities
(145)
(168)
Non-current liabilities
(48)
(83)
Equity
(466)
(388)

 

 
For the year ended December 31
 
2022
2021
2020
 
$ millions
$ millions
$ millions
 
Sales
723
528
359
Operating Income
146
105
29
Depreciation and amortization
34
38
37
Operating income before depreciation and amortization
180
143
66
Net Income
116
96
23
Total Comprehensive income
78
104
40

  B.
Business Acquisition and Divestiture
     
  (1)

As part of the Company's strategy to divest low synergy businesses and non-core business activities, in March 2022, the Company completed the sale of its 50% share in its joint venture, Novetide Ltd., for a consideration of $33 million, of which $8 million represents an estimate for the fair value of a contingent consideration. As a result, the Company recognized a capital gain of $22 million.

     
  (2)

Further to the acquisition of Nobian’s holding in Sal Vesta (51%) in 2021, which was part of the partnership termination agreement between the Company and Nobian, on February 3, 2023, the Company signed an agreement for the sale of its 100% shares in Sal Vesta to Salins Group for a consideration of $13 million. As part of the transaction, the Company engaged in a long-term take-or-pay supply agreement for all the vacuum salt produced at ICL Iberia. The closing date is expected in the first quarter of 2023. No significant impact is expected on the Company’s financial statements.